Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Camsirubicin |
Synonyms | |
Therapy Description |
Camsirubicin (GPX-150) is a doxorubicin analogue that intercalates DNA and leads to apoptosis in tumor cells (PMID: 31016866). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Camsirubicin | GPX150|GPX-150 | Chemotherapy - Anthracycline 13 | Camsirubicin (GPX-150) is a doxorubicin analogue that intercalates DNA and leads to apoptosis in tumor cells (PMID: 31016866). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02267083 | Phase II | Camsirubicin | Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma | Completed | USA | 0 |